A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma

PLoS Neglected Tropical Diseases

Volumn 7, Issue 8, 2013, Pages

  West, Sheila K ^a   Bailey, Robin ^b   Munoz, Beatriz ^a   Edwards, Tansy ^b   Mkocha, Harran ^c   Gaydos, Charlotte ^d   Lietman, Thomas ^e   Porco, Travis ^e   Mabey, David ^b   Quinn, Thomas C ^f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Kongwa Trachoma Project   (Tanzania)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; TETRACYCLINE;

ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; INFANT; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE DRUG DOSE; TRACHOMA;

EID: 84883395960     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002415     Document Type: Article

References (17)

1. Mariotti S, Pascolini D, Rose-Nussbaumer J, (2009) Trachoma: Global Magnitude of a preventable cause of blindness. Br J Ophthalmol 93: 563-568.
2. Frick KD, Basilion EV, Hanson CL, Colchero MA, (2003) Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol 10: 121-132.
3. West SK, (2004) Trachoma: new assault on an ancient disease. Prog Retin Eye Res 23: 381-401.
4. Solomon AW, Holland MJ, Burton MJ, et al. (2003) Strategies for control of trachoma: observational study with quantitative PCR. Lancet 362: 198-204.
5. Hu VH, Harding-Esch EM, Burton MJ, Bailey RL, Kadimpeul J, et al. (2010) Epidemiology and control of Trachoma: A systematic Review. Trop Med Int Health 15: 673-691.
6. West SK, Munoz B, Mkocha H, Gaydos C, Quinn T, (2011) Number of Years of Annual Mass Treatment with Azithromycin Needed to Control Trachoma in Hyper-endemic Communities. J Infect Dis 204: 268-273.
7. Burton MJ, Holland MJ, Makalo P, et al. (2005) Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 365: 1321-1328.
8. Munoz B, Mkocha H, Gaydos C, Quinn T, West SK, (2011) Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci 52: 8806-8810.
9. Hotez PJ, Molyneux DH, Fenwick A, et al. (2007) Control of neglected tropical diseases. New Engl J Med 357: 1018-1027.
10. Stare D, Harding-Esch EM, Munoz B, et al. (2011) Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: The Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia. Ophthalmic Epidemiol 18: 20-29.
11. Chaudhary MA, Moulton LH, (2006) A SAS Macro for constrained randomization of group-randomized designs. Comput Methods Programs BioMed 83: 205-210.
12. Thylefors B, Dawson C, Jones BR, West SK, Taylor HR, (1987) A simple system for the assessment of trachoma and its complications. Bull WHO 65: 477-83.
13. Ssemanda EN, Levens J, Mkocha H, Munoz B, West SK, (2012) Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds. PLoS Negl Trop Dis 6 (3) (): e1576.
14. West SK, Munoz B, Mkocha H, et al. (2005) Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366: 1296-1300.
15. Biebesheimer JB, House J, Hong KC, et al. (2009) Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions. Ophthalmology 116: 2047-2050.
16. Solomon AW, Harding-Esch E, Alexander ND, et al. (2008) Two doses of azithromycin to eliminate trachoma in a Tanzanian community. New Engl J Med 358: 1870-1871.
17. Gebre T, Zerihun M, Genet A, et al. (2012) Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet 379: 143-151.